EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
WG 4
We need to discuss the kind of documents that we should have ready for the meeting of WG4. I can ask Crt to put together an overview document with different types of accreditation that exist to provide some food for thought to the group. In addition, a short presentation on CTF in general would be beneficial since not all group members have been involved in the CTF process.
Labour mobility
Did Mairead McGuiness get back to you?
Did you both have a chance to review the labour mobility survey report?
I prepared an overview of the guest that were invited to Cannes (available HERE). At the board meeting you discussed that the focus should be put on doctors and patients
EMVO
Rob and I will be attending the next EMVO Stakeholder meeting on 25th October during which the hospital platform should be discussed. The following information was shared with EMVO (presentation). Emphasis will be put on our asking the EMVO secretariat to reach out to NMVOs and facilitate the hospital stakeholder involvement.
Follow up with members
I will approach each national member president (in case of FR and DE I will send the email to their new “inbox” that should be used for all EAHP matters) to inquire about the status of FMD implementation. The following document outlines the information that will be collected.
5) Miscellaneous
Video pledge/ EAHP statement for EAAD
The video pledge should be very short (30 seconds to 1 minute). The statement should outline how EAHP keeps antibiotics working. We could mention antimicrobial stewardship teams in our member countries, our position paper and the ACASEM.
EMA work plan 2018/2019
The board members did not have many comments. Nenad suggested to add Health Technology Assessment in the “Early access to medicines” and “Benefit-risk assessment” fields.
Background information on organisations
During the board meeting you asked me to look further into the European Society for Patient Adherence, Compliance and Persistence (ESPACOMP) that was mentioned by one of our industry advisory group members.
ESPACOMP is a non-profit established to promote the science concerned with the quantitative assessment of what patients do with medicines they have been prescribed. They are not registered in the EU’s transparency register. Moreover, it is very difficult to figure out who sits behind the association. The following persons are in their Executive Committee, Sabina de Geest (KU Leuven), Juliet Foster, Dyfrig Hughes (Bangor University), Marie-Paule Schneider, Bernard Vrijens (AARDEX group), Leah Zullig, Liset van Dijk, Alpana Mair, Sabina De Geest, Monique Elseviers, Eric Van Ganse , Robert Vander Stichele and Bernand Vrijens.
Their main activity is their annual congress which has on average 150 participants. Their other two main activities are ABC – Ascertaining Barriers for Compliance (a cooperation of łodz Medical University, KU Leuven, AARDEX group and Keele University) and the Healthcare Compliance Packaging Council (aims at educating the healthcare sector about packaging that improves the life of patients). The latter project is funded by industry (Abott, ACG Worldwide, Amcor, Astrazeneca, Bilcare, Constantia, Roche, Honeywell, IMASafe, Klöckner Pentplast, MTC Pharma Center, Novartis, Palladio, Sanofi, Storaenso, Tjoapack, Westrock).
EXPH – Draft Opinion on Benchmarking access to healthcare in the EU
We need to discuss if we provide comments to the draft. The deadline is 26th October.
